Jeff Yass’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88B Buy
3,896,100
+97,100
+3% +$25.8M 0.15% 115
2026
Q1
$416M Buy
3,799,000
+593,700
+19% +$84.6M 0.05% 311
2025
Q4
$533M Buy
3,205,300
+192,200
+6% +$32.2M 0.06% 250
2025
Q3
$590M Buy
3,013,100
+932,400
+45% +$153M 0.07% 226
2025
Q2
$188M Buy
2,080,700
+658,700
+46% +$52M 0.03% 473
2025
Q1
$84.9M Buy
1,422,000
+111,500
+9% +$10.3M 0.01% 726
2024
Q4
$174M Buy
1,310,500
+864,400
+194% +$81.1M 0.03% 472
2024
Q3
$23.4M Buy
446,100
+242,700
+119% +$11.4M ﹤0.01% 1668
2024
Q2
$12.3M Buy
203,400
+30,000
+17% +$2.08M ﹤0.01% 2233
2024
Q1
$12.9M Buy
+173,400
New +$12.8M ﹤0.01% 2282

Other funds holding ALAB

Jeff Yass's ALAB Position: Q2 2026 in Review

Jeff Yass reduced its Astera Labs (ALAB) stake by 55% in Q2 2026, selling an estimated $89.7M and leaving 272,491 shares worth $132M. The position accounts for 0.01% of the portfolio, ranked #796.

Jeff Yass first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 984 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Jeff Yass held 272,491 shares of Astera Labs worth $132M as of Q2 2026.
  • Jeff Yass sold 338,178 Astera Labs shares in Q2 2026, an estimated $89.7M.
  • Astera Labs made up 0.01% of Jeff Yass's portfolio in Q2 2026, its #796 holding.
  • Jeff Yass first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 984 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.